RecruitingPHASE1, PHASE2NCT02447874

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

Studying Sickle cell anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Emory University
Principal Investigator
Claudia Morris, MD
Emory University
Intervention
Arginine(drug)
Enrollment
21 target
Eligibility
7-21 years · All sexes
Timeline
2015 – 2026

Study locations (2)

Collaborators

Children's Healthcare of Atlanta · National Center for Complementary and Integrative Health (NCCIH)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02447874 on ClinicalTrials.gov

Other trials for Sickle cell anemia

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell anemia →

← Back to all trials